+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Suppositories Market - Global Forecast 2026-2032- Product Image
Suppositories Market - Global Forecast 2026-2032- Product Image
Sale

Suppositories Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6160599
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Suppositories Market is projected to reach USD 1.72 Billion in 2026. It is expected to continue growing at a CAGR of 6.16%, reaching USD 2.48 Billion by 2032.

Suppositories: Executive Summary and Strategic Context

Suppositories are solid dosage forms designed for administration through rectal, vaginal, or, less commonly, other mucosal routes. Their relevance reflects the ability to deliver locally or systemically when oral administration is unsuitable, including situations involving nausea, swallowing difficulty, gastrointestinal limitations, or the need for targeted treatment. Product performance depends on formulation, melting or dissolution behavior, stability, packaging, administration convenience, and patient acceptability.

How Formulation, Delivery, and Regulation Are Reshaping Suppositories

The landscape is being transformed by stronger attention to patient-centric delivery, excipient compatibility, dose uniformity, and manufacturing consistency. Advances in molding, automated filling, lipid and water-soluble bases, and controlled-release formulation are supporting more predictable performance. At the same time, regulators and healthcare providers are emphasizing quality systems, microbiological control, product labeling, safe administration, and evidence appropriate to the intended route and indication. Sustainability pressures are also encouraging examination of packaging materials, energy use, and manufacturing waste.

Artificial Intelligence Is Strengthening Development and Operations

Artificial intelligence can support suppository development by analyzing formulation variables, identifying relationships among excipients and release behavior, and prioritizing experiments for laboratory evaluation. In manufacturing, machine-learning tools can assist with process monitoring, visual inspection, deviation detection, maintenance planning, and batch-record review. Its value remains dependent on representative data, validated models, human oversight, cybersecurity, and compliance with applicable quality and privacy requirements. AI should therefore augment pharmaceutical expertise rather than replace formulation science, clinical judgment, or quality assurance.

Regional Insights: Diverse Needs Across Global Suppository Markets

North America is shaped by regulated manufacturing, established healthcare systems, and demand for convenient dosage forms, while Latin America reflects varied regulatory environments, healthcare access, and local production capabilities. Europe places strong emphasis on harmonized quality expectations, patient safety, sustainability, and pharmaceutical stewardship. The Middle East is influenced by centralized procurement in some settings, specialty-care requirements, and climatic considerations for storage. Africa presents diverse access conditions, supply-chain constraints, and a need for robust products that can withstand distribution challenges. Asia-Pacific combines advanced pharmaceutical manufacturing hubs with large and varied patient populations, creating opportunities for route-specific products adapted to local clinical practice and affordability needs.

Group Insights: Trade Blocs and Alliances Shape Access and Standards

ASEAN markets require attention to differing regulatory pathways, distribution systems, and healthcare infrastructure despite regional cooperation. BRICS members span highly distinct pharmaceutical capabilities, procurement models, and domestic manufacturing priorities, making country-level execution essential. The European Union benefits from regulatory coordination while retaining national differences in reimbursement and clinical practice. G7 countries generally combine sophisticated quality systems with high expectations for evidence, safety, and patient usability. GCC markets are influenced by centralized purchasing, import dependence in selected product categories, and requirements suited to hot climates. NATO countries do not form a single pharmaceutical market, but their overlapping focus on supply resilience and critical-product continuity can affect procurement and contingency planning.

Country Insights: Local Regulation and Care Pathways Matter

Australia and Canada combine mature regulatory systems with geographically dispersed care delivery. Brazil and Mexico require close attention to national registration, public procurement, and distribution complexity. China and India pair large patient populations with substantial domestic pharmaceutical capabilities, although regional access and regulatory processes vary. Japan and South Korea emphasize technical quality, manufacturing precision, and established clinical oversight. France, Germany, Italy, and Spain operate within the European framework while retaining distinct reimbursement, prescribing, and procurement dynamics. The United Kingdom has its own regulatory and health-system processes following its separation from the European Union. Russia presents a distinct regulatory and supply environment. The United States places significant weight on product quality, labeling, manufacturing controls, and route-specific clinical and regulatory evidence.

Action Plan for Leaders: Build Reliable, Patient-Centered Suppository Portfolios

Industry leaders should prioritize formulations that balance stability, manufacturability, dose performance, and ease of administration. They should segment development around clearly defined clinical and patient needs, validate critical process parameters, and strengthen supplier qualification for active ingredients, excipients, packaging, and specialized equipment. Regional plans should account for registration requirements, storage conditions, reimbursement, procurement, and local healthcare workflows. Digital investments should begin with governed data, measurable quality use cases, and validation before expanding AI across development or production. Finally, leaders should engage clinicians and patients early, communicate administration instructions clearly, and track real-world tolerability, adherence, complaints, and supply continuity.

Research Methodology: Evidence-Led Assessment of Suppository Dynamics

This executive summary uses a structured qualitative assessment of suppository dosage forms, covering route of administration, formulation science, manufacturing, regulation, healthcare delivery, technology, and supply-chain considerations. The analysis organizes implications across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, and then examines ASEAN, BRICS, the European Union, the G7, the GCC, NATO, and the specified countries. Findings are framed as strategic themes rather than numerical market claims and should be complemented by primary interviews, regulatory reviews, product-level quality evidence, clinical literature, and country-specific reimbursement and procurement research before investment decisions.

Conclusion: Quality, Usability, and Resilience Define Suppository Opportunity

Suppositories remain relevant where local treatment, systemic delivery, or an alternative to oral administration offers clinical value. Their future development will be determined by dependable formulation performance, patient acceptability, rigorous quality control, regulatory alignment, and resilient supply networks. Organizations that combine route-specific science with regional execution, responsible digital adoption, and transparent patient support will be better positioned to improve access and sustain product quality across diverse healthcare environments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Suppositories Market, by Product Type
7.1. Introduction
7.2. Rectal Suppositories
7.3. Urethral Suppositories
7.4. Vaginal Suppositories
8. Suppositories Market, by Material Type
8.1. Introduction
8.2. Emulsifying Bases
8.3. Fatty Bases
8.4. Glycerinated Gelatin Base
8.5. Polyethylene Glycol Base
8.5.1. PEG 3350
8.5.2. PEG 4000
8.6. Water-Soluble Bases
9. Suppositories Market, by Prescription Type
9.1. Introduction
9.2. Over-the-Counter (OTC) Drugs
9.3. Prescription Drugs (Rx)
10. Suppositories Market, by Therapeutic Application
10.1. Introduction
10.2. Analgesic
10.2.1. Acetaminophen Analgesic
10.2.2. NSAID Analgesic
10.3. Anti Inflammatory
10.4. Antibacterial & Antifungal
10.5. Antiemetic
10.6. Antihemorrhoidal
10.6.1. Non Steroidal Formulation
10.6.2. Steroidal Formulation
10.7. Laxative
11. Suppositories Market, by End User
11.1. Introduction
11.2. Home Care
11.3. Hospitals & Clinics
12. Suppositories Market, by Distribution Channel
12.1. Introduction
12.2. Offline Pharmacy
12.3. Online Pharmacy
13. Suppositories Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Suppositories Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Suppositories Market, by Country
15.1. Introduction
15.2. United States
15.3. Germany
15.4. China
15.5. United Kingdom
15.6. India
15.7. Japan
15.8. Russia
15.9. Brazil
15.10. Canada
15.11. Italy
15.12. Mexico
15.13. France
15.14. Spain
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Adragos Pharma GmbH
17.2. Aenova Group
17.3. Aliyan Pharmaceuticals LLP
17.4. Aspen Holdings
17.5. Bausch Health Companies Inc.
17.6. Bayer AG
17.7. Bliss GVS Pharma Ltd
17.8. Church & Dwight Co., Inc.
17.9. Cipla Limited
17.10. Corden Pharma
17.11. Gulf Pharmaceutical Industries
17.12. Haleon Group of Companies
17.13. LGM Pharma, LLC
17.14. Novartis AG
17.15. Pfizer Inc.
17.16. Prestige Consumer Healthcare Inc.
17.17. Recipharm AB
17.18. SANOFI WINTHROP INDUSTRIE
17.19. Sun Pharmaceutical Industries Ltd.
17.20. Teva Pharmaceutical Industries Ltd.
17.21. Zydus Group
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Suppositories Market, Years Considered for the Study
FIGURE 2. Global Suppositories Market, Research Design
FIGURE 3. Global Suppositories Market, Research Framework
FIGURE 4. Global Suppositories Market, Data Triangulation
FIGURE 5. Global Suppositories Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Suppositories Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Suppositories Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Suppositories Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 9. Global Suppositories Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Suppositories Market Size, by Prescription Type, 2025 vs 2032 (%)
FIGURE 11. Global Suppositories Market Size, by Prescription Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Suppositories Market Size, by Therapeutic Application, 2025 vs 2032 (%)
FIGURE 13. Global Suppositories Market Size, by Therapeutic Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Suppositories Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Suppositories Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Suppositories Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Suppositories Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Suppositories Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Suppositories Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Suppositories Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Suppositories Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Suppositories Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Suppositories Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Suppositories Market Segmentation & Coverage
TABLE 2. Global Suppositories Market Size, 2017-2032 (USD Million)
TABLE 3. Global Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Rectal Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Rectal Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Rectal Suppositories Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Urethral Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Urethral Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Urethral Suppositories Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Vaginal Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Vaginal Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Vaginal Suppositories Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 14. Global Emulsifying Bases Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Emulsifying Bases Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Emulsifying Bases Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Fatty Bases Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Fatty Bases Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Fatty Bases Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Glycerinated Gelatin Base Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Glycerinated Gelatin Base Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Glycerinated Gelatin Base Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Polyethylene Glycol Base Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Polyethylene Glycol Base Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Polyethylene Glycol Base Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global PEG 3350 Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global PEG 3350 Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global PEG 3350 Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global PEG 4000 Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global PEG 4000 Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global PEG 4000 Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Water-Soluble Bases Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Water-Soluble Bases Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Water-Soluble Bases Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 36. Global Over-the-Counter (OTC) Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Over-the-Counter (OTC) Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Over-the-Counter (OTC) Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Prescription Drugs (Rx) Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Prescription Drugs (Rx) Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Prescription Drugs (Rx) Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 43. Global Analgesic Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Analgesic Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Analgesic Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Acetaminophen Analgesic Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Acetaminophen Analgesic Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Acetaminophen Analgesic Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global NSAID Analgesic Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global NSAID Analgesic Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global NSAID Analgesic Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Anti Inflammatory Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Anti Inflammatory Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Anti Inflammatory Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Antibacterial & Antifungal Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Antibacterial & Antifungal Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Antibacterial & Antifungal Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Antiemetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Antiemetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Antiemetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Antihemorrhoidal Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Antihemorrhoidal Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Antihemorrhoidal Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Non Steroidal Formulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Non Steroidal Formulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Non Steroidal Formulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Steroidal Formulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Steroidal Formulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Steroidal Formulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Laxative Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Laxative Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Laxative Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 81. Global Offline Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Offline Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Offline Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. North America Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. North America Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. North America Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 101. North America Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 102. North America Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 103. North America Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 104. North America Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 105. North America Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 106. North America Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. North America Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. Latin America Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Latin America Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. Latin America Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 111. Latin America Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 112. Latin America Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 113. Latin America Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 114. Latin America Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 115. Latin America Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 116. Latin America Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Latin America Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. Europe Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Europe Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. Europe Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 121. Europe Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 122. Europe Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 123. Europe Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 124. Europe Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 125. Europe Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 126. Europe Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Europe Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. Middle East Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Middle East Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. Middle East Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 131. Middle East Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 132. Middle East Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 133. Middle East Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 134. Middle East Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 135. Middle East Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 136. Middle East Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. Middle East Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. Africa Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Africa Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. Africa Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 141. Africa Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 142. Africa Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 143. Africa Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 144. Africa Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 145. Africa Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 146. Africa Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Africa Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. Global Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. ASEAN Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. ASEAN Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. ASEAN Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 152. ASEAN Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 153. ASEAN Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 154. ASEAN Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 155. ASEAN Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 156. ASEAN Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 157. ASEAN Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. ASEAN Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. GCC Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. GCC Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. GCC Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 162. GCC Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 163. GCC Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 164. GCC Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 165. GCC Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 166. GCC Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 167. GCC Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. GCC Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. European Union Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. European Union Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. European Union Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 172. European Union Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 173. European Union Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 174. European Union Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 175. European Union Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 176. European Union Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 177. European Union Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. European Union Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. BRICS Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. BRICS Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. BRICS Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 182. BRICS Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 183. BRICS Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 184. BRICS Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 185. BRICS Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 186. BRICS Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 187. BRICS Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. BRICS Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. G7 Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. G7 Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. G7 Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 192. G7 Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 193. G7 Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 194. G7 Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 195. G7 Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 196. G7 Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 197. G7 Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. G7 Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. NATO Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. NATO Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. NATO Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 202. NATO Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 203. NATO Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 204. NATO Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 205. NATO Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 206. NATO Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 207. NATO Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. NATO Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. Global Suppositories Market Size, by Country, 2017-2032 (USD Million)
TABLE 210. United States Suppositories Market Size, 2017-2032 (USD Million)
TABLE 211. United States Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. United States Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 213. United States Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 214. United States Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 215. United States Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 216. United States Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 217. United States Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 218. United States Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. United States Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Germany Suppositories Market Size, 2017-2032 (USD Million)
TABLE 221. Germany Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Germany Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 223. Germany Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 224. Germany Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 225. Germany Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 226. Germany Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 227. Germany Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 228. Germany Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Germany Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. China Suppositories Market Size, 2017-2032 (USD Million)
TABLE 231. China Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. China Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 233. China Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 234. China Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 235. China Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 236. China Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 237. China Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 238. China Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. China Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. United Kingdom Suppositories Market Size, 2017-2032 (USD Million)
TABLE 241. United Kingdom Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. United Kingdom Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 243. United Kingdom Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 244. United Kingdom Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 245. United Kingdom Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 246. United Kingdom Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 247. United Kingdom Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 248. United Kingdom Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. United Kingdom Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. India Suppositories Market Size, 2017-2032 (USD Million)
TABLE 251. India Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 252. India Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 253. India Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 254. India Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 255. India Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 256. India Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 257. India Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 258. India Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. India Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Japan Suppositories Market Size, 2017-2032 (USD Million)
TABLE 261. Japan Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. Japan Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 263. Japan Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 264. Japan Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 265. Japan Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 266. Japan Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 267. Japan Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 268. Japan Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Japan Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Russia Suppositories Market Size, 2017-2032 (USD Million)
TABLE 271. Russia Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. Russia Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 273. Russia Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 274. Russia Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 275. Russia Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 276. Russia Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 277. Russia Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 278. Russia Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Russia Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 280. Brazil Suppositories Market Size, 2017-2032 (USD Million)
TABLE 281. Brazil Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 282. Brazil Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 283. Brazil Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 284. Brazil Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 285. Brazil Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 286. Brazil Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 287. Brazil Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 288. Brazil Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Brazil Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 290. Canada Suppositories Market Size, 2017-2032 (USD Million)
TABLE 291. Canada Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 292. Canada Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 293. Canada Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 294. Canada Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 295. Canada Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 296. Canada Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 297. Canada Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 298. Canada Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Canada Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 300. Italy Suppositories Market Size, 2017-2032 (USD Million)
TABLE 301. Italy Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 302. Italy Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 303. Italy Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 304. Italy Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 305. Italy Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 306. Italy Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 307. Italy Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 308. Italy Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. Italy Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 310. Mexico Suppositories Market Size, 2017-2032 (USD Million)
TABLE 311. Mexico Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 312. Mexico Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 313. Mexico Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 314. Mexico Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 315. Mexico Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 316. Mexico Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 317. Mexico Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 318. Mexico Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. Mexico Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 320. France Suppositories Market Size, 2017-2032 (USD Million)
TABLE 321. France Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 322. France Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 323. France Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 324. France Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 325. France Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 326. France Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 327. France Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 328. France Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 329. France Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 330. Spain Suppositories Market Size, 2017-2032 (USD Million)
TABLE 331. Spain Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 332. Spain Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 333. Spain Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 334. Spain Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 335. Spain Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 336. Spain Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 337. Spain Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 338. Spain Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 339. Spain Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 340. Australia Suppositories Market Size, 2017-2032 (USD Million)
TABLE 341. Australia Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 342. Australia Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 343. Australia Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 344. Australia Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 345. Australia Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 346. Australia Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 347. Australia Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 348. Australia Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 349. Australia Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 350. South Korea Suppositories Market Size, 2017-2032 (USD Million)
TABLE 351. South Korea Suppositories Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 352. South Korea Suppositories Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 353. South Korea Suppositories Market Size, by Polyethylene Glycol Base, 2017-2032 (USD Million)
TABLE 354. South Korea Suppositories Market Size, by Prescription Type, 2017-2032 (USD Million)
TABLE 355. South Korea Suppositories Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 356. South Korea Suppositories Market Size, by Analgesic, 2017-2032 (USD Million)
TABLE 357. South Korea Suppositories Market Size, by Antihemorrhoidal, 2017-2032 (USD Million)
TABLE 358. South Korea Suppositories Market Size, by End User, 2017-2032 (USD Million)
TABLE 359. South Korea Suppositories Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 360. Global Suppositories Market Share, by Key Player, 2025
TABLE 361. Global Suppositories Market, Key Experts

Companies Mentioned

  • Adragos Pharma GmbH
  • Aenova Group
  • Aliyan Pharmaceuticals LLP
  • Aspen Holdings
  • Bausch Health Companies Inc.
  • Bayer AG
  • Bliss GVS Pharma Ltd
  • Church & Dwight Co., Inc.
  • Cipla Limited
  • Corden Pharma
  • Gulf Pharmaceutical Industries
  • Haleon Group of Companies
  • LGM Pharma, LLC
  • Novartis AG
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Recipharm AB
  • SANOFI WINTHROP INDUSTRIE
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Group

Related Topics

Related Reports

Suppositories Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Distribution Channel - Product Image

Suppositories Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
Transmucosal Drug Delivery Systems Market - Product Image

Transmucosal Drug Delivery Systems Market

  • Report
  • 150 Pages
  • Global
From
Transmucosal Drug Delivery Devices Market Report 2026 - Product Image

Transmucosal Drug Delivery Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Rx Dermatology Topical Drug Delivery Market Report 2026 - Product Image

Rx Dermatology Topical Drug Delivery Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Advanced Pharmaceutical and Herbal Nanoscience for Targeted Drug Delivery Systems Part II - Product Image

Advanced Pharmaceutical and Herbal Nanoscience for Targeted Drug Delivery Systems Part II

  • Book
Copyright © 2002-2026 Research and Markets. All Rights Reserved.